UNCY - Unicycive Therapeutics Inc
IEX Last Trade
0.3317
-0.011 -3.346%
Share volume: 1,183,547
Last Updated: Fri 30 Aug 2024 09:59:25 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.34
-0.01
-3.24%
Summary score
31%
Profitability
33%
Dept financing
22%
Liquidity
33%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2019 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
102.63%
Return on assets
-49.34%
Return on sales
-603.27%
Return on invested capital
106.28%
Total debt ratio
67.5%
Debt ratio change over timeo
0.27%
Current Ratio
2.85%
Quick Ratio
2.85%
Cash Position Ratio
2.4%
Short-term ratios 31-Dec-2022 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-38.35%
Return on assets
-27.34%
Return on sales
-622.52%
Return on invested capital
50.27%
Total debt ratio
85.22%
Debt ratio change over timeo
1.11%
Current Ratio
1.26%
Quick Ratio
1.26%
Cash Position Ratio
1.06%
Last quarter ratios 31-Dec-2023
The data are presented for the financials results of the last quarter.
Return on equity
181.96%
Return on assets
-44.48%
Return on sales
0%
Return on invested capital
41.4%
Total debt ratio
126.84%
Debt ratio change over time
2.06%
Current Ratio
0.76%
Quick Ratio
0.76%
Cash Position Ratio
0.55%
Performance ratios (change over 4 years) 31-Dec-2019 - 31-Dec-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-4.07%
Return on assets
-166.49%
Return on sales
-455.78%
Return on invested capital
8.9%
Total debt ratio
26.74%
Debt ratio change over time
0.27%
Current Ratio
2.1%
Quick Ratio
2.1%
Cash Position Ratio
1.56%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | UNCY | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 102.63% | 10.2% | 35.82% | 7.59% |
| Return on assets | -49.34% | 2.89% | 3.31% | 5.76% |
| Return on sales | -603.27% | 29.84% | 34.06% | 41.2% |
| Return on invested capital | 106.28% | 3.06% | 5.78% | 20.17% |
| Profitability | 50% | 34% | 45% | 57% |
| Total debt ratio | 67.5% | 91.31% | 89.91% | 26.84% |
| Debt ratio change over time | 0.27% | 295.05% | -10.03% | 1.11% |
| Dept financing | 19% | 50% | 25% | 7% |
| Current Ratio | 1.26% | 0.92% | 2.61% | 5.44% |
| Quick Ratio | 1.26% | 0.8% | 2.24% | 4.68% |
| Cash Position Ratio | 1.06% | 0.31% | 1.72% | 2.92% |
| Liquididy | 61% | 17% | 32% | 71% |
| Short-term ratios | UNCY | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -38.35% | 9.95% | 27.09% | 4.01% |
| Return on assets | -27.34% | 2.47% | 2.17% | 3.36% |
| Return on sales | -622.52% | 24.58% | 28.87% | 32.26% |
| Return on invested capital | 50.27% | 1.71% | 5.84% | 9.7% |
| Profitability | 25% | 47% | 66% | 59% |
| Total debt ratio | 85.22% | 91.02% | 92.9% | 21.89% |
| Debt ratio change over time | 1.11% | 107.3% | -84.55% | 1.71% |
| Dept financing | 23% | 49% | 25% | 6% |
| Current Ratio | 1.26% | 0.92% | 2.61% | 5.44% |
| Quick Ratio | 1.26% | 0.8% | 2.24% | 4.68% |
| Cash Position Ratio | 1.06% | 0.31% | 1.72% | 2.92% |
| Liquididy | 22% | 11% | 39% | 75% |